4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-025558
SVP, CFO sold 7,918 shares at an average $2.04 ($16,131)
From the SEC's structured data for this filing
Trades in this filing
Hyllengren Eric J · SVP, CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-16 | Sale : show line 1 in the form | −6,199 | $2.04 | $12,627 | 227,861 | D |
| 2023-05-16 | Sale : show line 2 in the form | −1,719 | $2.04 | $3,503 | 226,142 | D |
| Open-market sales · 7,918 sh · avg $2.04 · $16,131 | ||||||
Loading xslF345X04/form4.xml…